ESM Methods Protein extraction and western blot analysis Protein extraction was performed as previously described [1]. 2 g protein was loaded on SDSPAGE and immunoblotted with antibodies to mouse AKT (1:1, Cell Signaling Technology, Danvers, MA, USA), phosphorakt (Ser473; 1:1, Cell Signaling Technology), AMPKα1 (1:1, Cell Signaling Technology) or phosphorampkα1 (Thr172; 1:1, Cell Signaling Technology). HRPlabeled goat antirabbit IgG (1:4, KPL, Gaithersburg, MD, USA) was used as secondary antibody. Chemiluminescent detection was performed by using ECL western blot detection kit (BIORAD, Hercules, CA, UAS) in Image Quant LAS 4 mini (GE Healthcare, Piscataway, NJ, USA). Total RNA isolation and quantitative realtime PCR Total RNA was isolated with TRIZOL reagent (TAKARA, Dalian, China). The cdna was synthesized using M MLV reverse transcriptase (Invitrogen, Carlsbad, CA, USA) and oligo (dt)18 primers according to manufacturer s protocol. Quantitative realtime PCR was performed using itaq Universal SYBR Green Supermix (BIORAD) in BIORAD MyIQ2 Real Time PCR system. Relative mrna expression was determined by the ΔΔCt method and normalized to Gapdh. The primer sequences were listed in ESM Table 2. Immunohistochemistry and ELISA Immunohistochemistry stains with MAC2 antibody (Bio Legend, San Diego, CA, USA) for total macrophages in mice EAT was as previously described [2]. The serum TNFα, IL6 and MCP1 levels were measured
using mouse ELISA kits (BD Bioscience) according to manufacturer s protocols. EAT stromal vascular fraction (SVF) isolation Stromal vascular cells were isolated as previously described [3] with some minor modifications. Briefly, mouse EAT were excised, minced and incubated in 2 mg/ml Type II Collagenase (SigmaAldrich, St. Louis, MO, USA) at 37 C for 2 min. To remove adipocytes, the digesta were passed through a 75 μm filter. And then the cells were washed with PBS supplemented with.5% BSA, which was followed by red blood cell lysis for 5 min. Flow cytometry analysis For flow cytometry analysis, SVF or other cells were incubated with Fc Block (BD Biosciences, San Diego, USA) for 15 min on ice, and then were directly conjugated with the corresponding antibodies for 3 min at 4 C. All antibodies were listed ESM Table 3. The cells were identified by flow cytometer MoFlo XDP (Beckman Coulter, Fullerton, CA, USA) and data were analyzed using Summit 5.2. Small interfering (si)rna sirnas against Ampk 1 (also known as Prkaa1) and a scrambled sirna as control were purchased from Sangon Biotech (Shanghai, China). The sirna sequences applied to target Ampk 1 were: 5 GCAAUCAAGCAGUUGGAUU dtdt3 (sense) and 5 AAUCCAACUGCUUGAUUGCdTdT3 (antisense). The scrambled sirna sequences employed as a negative control were 5 GCAGAA CUGACGGUUAAUUdTdT3 (sense) and 5 AAUUAACCGUCAGUUCUGCdT
dt3 (antisense). RAW264.7 and PCM were transfection with sirnas using Lipofectamine 2 (Invitrogen) according to the manufacture s protocol. References 1. Dong J, Zhang X, Zhang L, et al. (214) Quercetin reduces obesityassociated ATM infiltration and inflammation in mice: a mechanism including AMPK 1/SIRT1. J Lipid Res 55: 363374 2. Xu N, Zhang L, Dong J, et al. (214) Lowdose diet supplement of a natural flavonoid, luteolin, ameliorates dietinduced obesity and insulin resistance in mice. Mol Nutr Food Res 58: 12581268 3. Bao B, Chen YG, Zhang L, et al. (213) Momordica charantia (Bitter Melon) reduces obesityassociated macrophage and mast cell infiltration as well as inflammatory cytokine expression in adipose tissues. PLoS One 8: e8475
Blood glucose (mmol/l) Blood glucose (% of initial) a 17 b 12 15 13 11 9 7 5 3 2 4 6 8 1 12 Time (min) 11 1 9 8 7 6 5 4 2 4 6 8 1 12 Time (min) ESM Figure 1 GTT (a) and insulin tolerance test (b) assays were performed at 15weekold mice. Black circles, HFD; white circles, LFD; grey triangles, HFD. All data were presented as mean ± SEM, n=8 per group, oneway ANOVA with Duncan s post hoc test relative to HFD, P<.5, P<.1.
a EAT weight (g) 3 2 1 b SAT weight (g) 2.5 2 1.5 1.5 c Food intake (kcal/week/2g body weight) 8 6 4 2 N.S ESM Figure 2 Weights of EAT (a) and SAT (b) of mice. (c) Energy intake per 2 g body weight of mice every week treatment. Black bars, HFD; white bars, HFD2; grey bars, HFD1; hatched bars, LFD. All data were presented as mean ± SEM, n=8 per group, oneway ANOVA with Duncan s post hoc test relative to HFD, P<.5, P<.1.
a 1 1 1 1 HFD HFD2 HFD1 LFD b MAC2 area (%).5.4.3.2.1 c 1 5 Mac per g adipose 2.6 2.4 2.2 2 1.8 1.6 1.4 1.2 1 ESM Figure 3 Dietary decreased macrophage accumulation into EAT. (a) MAC2 immunohistochemistry of EAT; scale bars: 1 μm. (b) Quantification of MAC2 area percent. (c) Quantification of macrophages per g EAT by flow cytometry. Black bars, HFD; white bars, HFD2; grey bars, HFD1; hatched bars, LFD. All data were presented as mean ± SEM, n=8 per group, oneway ANOVA with Duncan s post hoc test relative to HFD, P<.5, P<.1. Mac, macrophage.
a 3 25 2 15 1 5 (μmol/l ) 5 1 2 b Tnfα mrna (fold) 2 16 12 8 4 (μmol/l) 1 c 2 16 12 8 4 5 2 (μmol/l) 5 1 2 d 1 e 1 f 1, 8 6 4 2 (μmol/l) 5 1 2 Tnfα mrna (fold) 8 6 4 2 (μmol/l) 5 1 2 8, 6, 4, 2, (μmol/l) 5 1 2 g (μmol/l) 5 1 j 1 8 6 4 2 35 3 25 2 15 1 5 (μmol/l) 5 1 2 2 h Tnfα mrna (fold) (μmol/l) 5 1 k Tnfα mrna (fold) 15 12 9 6 3 14 12 1 8 6 4 2 (μmol/l) 5 1 2 2 i 35 3 25 2 15 1 5 (μmol/l) 5 1 l 8 7 6 5 4 3 2 1 (μmol/l) 5 1 2 2
ESM Figure 4 reduced macrophage inflammation in dosedependent manner. RAW264.7 and PCM were pretreated with vehicle 5, 1 or 2 mol/l for 12 h, and then stimulated with 1 ng/ml for 4 h or for 48 h. The mrna levels of proinflammatory cytokine Mcp1, Tnfα and Il6 were detected in stimulated RAW264.7 (ac) and PCM (df), and stimulated RAW264.7 (gi) and PCM (jl). n=4 per group. All data were presented as mean ± SEM, n=4 per group, twotailed student s t test relative to or treatment, P<.5, P<.1.
a 35 3 25 2 15 1 5 2 b Tnfa mrna (fold) d e 12 f 1 8 9 6 6 4 Tnfa mrna (fold) 3 25 2 15 1 5 3 c 25 2 15 1 5 12, 9, 6, 3, g h i j 12 1 8 6 4 2 4 32 24 16 8 Tnfa mrna (fold) k Tnfa mrna (fold) 15 1 5 15 12 9 6 3 l 35 3 25 2 15 1 5 9 6 3
ESM Figure 5 suppressed or induced macrophage inflammation through activating AMPKα1. The mrna levels of Mcp1, Tnfα and Il6 were analyzed in stimulated RAW264.7 (ac) and PCM (df) or stimulated RAW264.7 (gi) and PCM (jl). All data were presented as mean ± SEM, n=4 per group, twotailed student s t test, P<.5, P<.1.
AMPK 1/ actin of RAW264.7 AMPK 1/ actin of PCM a b c 1.2 1. 1.2 1. AMPK 1 actin AMPK 1 actin RAW264.7 PCM.8.6.4.8.6.4.2 ESM Figure 6 sirnamediated knockdown of Ampkα1 in RAW264.7 and PCM. RAW264.7 and PCM were transfected with a negative control sirna () or a sirna targeting Ampkα1 for 72 h and lysed for immunoblots. (a) Immunoblots for AMPKα1 and actin and quantification of AMPKα1 to actin in RAW264.7 (b) and PCM (c). All data were presented as mean ± SEM, n=4 per group, twotailed student s t test, P<.5, P<.1.
a 25 2 15 1 b Tnf mrna (fold) 25 2 15 1 5 c 2 16 12 8 4 5 d e f 1 8 6 4 2 1 8 6 4 2 35 28 21 14 7 Tnf mrna (fold) 8 6 4 2 Tnf mrna (fold) Tnf mrna (fold) 12 1 8 6 4 2 12 1 8 6 4 2 8, g h i j k l 6, 4, 2, 3 2 1 8 6 4 2 ESM Figure 7 Ampk 1 silencing reserved the effects of on macrophage inflammation. The mrna levels of Mcp1, Tnfα and Il6 were detected in
stimulated RAW264.7 (ac) and PCM (df) or stimulated RAW264.7 (gi) and PCM (jl). All data were presented as mean ± SEM, n=4 per group, twotailed student s t test, P<.5, P<.1.
ESM Table 1. The composition of diets used in experiment Ingredient (g) LFD HFD HFD.1% Casein 2 2 2 LCystine 3 3 3 Corn starch 315 72.8 72.8 Malt dextrin 1 35 1 1 Sucrose 35 172.8 172.8 Cellulose 5 5 5 Soybean oil 25 25 25 Lard 2 177.5 177.5 Mineral Mix 126 1 1 1 Dicalciumphospate 13 13 13 Calcium carbonate 5.5 5.5 5.5 Potassium citrate 16.5 16.5 16.5 Vitamin Mix V11 1 1 1 Choline bitartrate 2 2 2 Luteolin.851 Total weight (g) 155 858.1 858.1 Total energy (kcal) 457 457 457 Note: a) LFD, low fat diet was based on the research diets D1245B diet; b) HFD, high fat diet was based on the research diets D12451diet; c), luteolin was added in diets as powders.
ESM Table 2. Primers for quantitative qpcr Gene Sequence of forward primers(5' to 3') Sequence of reverse primers(5' to 3') Tnf ACGGCATGGATCTCAAAGAC AGATAGCAAATCGGCTGACG Mcp1 CCCCAAGAAGGAATGGGTCC GGTTGTGGAAAAGGTAGTGG Il6 CCTTCCTACCCCAATTTCCAA AGATGAATTGGATGGTCTTGGTC Nos2 CCAAGCCCTCACCTACTTCC CTCTGAGGGCTGACACAAGG Arg1 CTCCAAGCCAAAGTCCTTAGAG AGGAGCTGTCATTAGGGACATC Cd36 ATGGGCTGTGATCGGAACTG GTCTTCCCAATAAGCATGTCTCC Plin2 GACCTTGTGTCCTCCGCTTAT CAACCGCAATTTGTGGCTC Gapdh CGTGTTCCTACCCCCAATGT TGTCATACTTGGCAGGTTTCT
ESM Table 3. Flow cytometry antibodies used in this study Cells Antibody name Supplier Catalog number Adipose tissue macrophages APC antimouse F4/8 BioLegend 123116 FITC antimouse CD26 (MMR) BioLegend 14174 PE antimouse CD11c ebioscience 12114 induced macrophages APC antimouse CD274 (B7H1,PDL1) BioLegend 124312 PE antimouse CD38 BioLegend 1278 induced macrophages APC antimouse CD36 ebioscience 17361 PE antimouse ABCA1 Novusbio NB415PE